π΅οΈ Harmony Biosciences Holdings, Inc. ($HRMY)
SEC insider & ownership activity, last 12 months Β· CIK 1802665 Β· every row links its SEC filing
Over the last 12 months insiders sold $3.6M with no open-market buying against it. Sandip Kapadia sold $2.6M through a program of 13 sale notices averaging $748K (AugβJan). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 2 sellers, $3.6M (7 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Sandip Kapadia | 0 | β | 5 | $2.6M | Jan 26, 2026 |
| Jeffrey M Dayno | 0 | β | 2 | $1.0M | Dec 12, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 11.3% | 13G | Jul 28, 2026 | filing β | |
| Marshman Fund Trust II | 10.6% | 13G | Feb 10, 2025 | filing β | |
| FMR LLC | 5.4% | 13G | Feb 5, 2026 | filing β | |
| Abigail P. Johnson | 5.4% | 13G | Feb 5, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Sandip Kapadia | $924K | Jul 2, 2026 | filing β |
| Sandip Kapadia | $1.8M | Jun 30, 2026 | filing β |
| Sandip Kapadia | $1.6M | Jun 26, 2026 | filing β |
| Sandip Kapadia | $154K | Jun 24, 2026 | filing β |
| Sandip Kapadia | $943K | Jun 9, 2026 | filing β |
| Sandip Kapadia | $70K | Jun 5, 2026 | filing β |
| Sandip Kapadia | $233K | Jun 4, 2026 | filing β |
| Sandip Kapadia | $1.4M | May 8, 2026 | filing β |
| Sandip Kapadia | $138K | Jan 26, 2026 | filing β |
| Sandip Kapadia | $755K | Jan 15, 2026 | filing β |
| Jeffrey M Dayno | $1.0M | Dec 12, 2025 | filing β |
| Sandip Kapadia | $765K | Dec 5, 2025 | filing β |
| Sandip Kapadia | $114K | Nov 21, 2025 | filing β |
| Sandip Kapadia | $788K | Aug 15, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 16, 2026 | filing β |
| Officer/director changes (5.02) | Jul 16, 2026 | filing β |
| Reg FD disclosure (7.01) | Jul 16, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing β |
| Shareholder vote (5.07) | May 14, 2026 | filing β |
| Earnings (2.02) | May 7, 2026 | filing β |
| Reg FD disclosure (7.01) | May 7, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing β |
| Officer/director changes (5.02) | Apr 14, 2026 | filing β |
| Reg FD disclosure (7.01) | Apr 14, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Apr 14, 2026 | filing β |
| Officer/director changes (5.02) | Mar 31, 2026 | filing β |
| Reg FD disclosure (7.01) | Mar 31, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing β |
| Earnings (2.02) | Feb 24, 2026 | filing β |
| Reg FD disclosure (7.01) | Feb 24, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing β |
| Earnings (2.02) | Jan 12, 2026 | filing β |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing β |
| Earnings (2.02) | Nov 4, 2025 | filing β |
| Reg FD disclosure (7.01) | Nov 4, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing β |
| Earnings (2.02) | Oct 23, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Oct 23, 2025 | filing β |
| Reg FD disclosure (7.01) | Sep 24, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Sep 24, 2025 | filing β |
| Earnings (2.02) | Aug 5, 2025 | filing β |
| Reg FD disclosure (7.01) | Aug 5, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing β |